SCHEMBL31369960

SCHEMBL31369960

O=C(O)CNCCc1cccc2cc[nH]c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
BACE1 P56817 1/20 0.43
PDPK1 O15530 1/20 0.42
BCHE P06276 3/20 0.40
PARP1 P09874 2/20 0.40
NR3C1 P04150 1/20 0.39
PGR P06401 1/20 0.39
NR3C2 P08235 1/20 0.39
AR P10275 1/20 0.39
MAPK8 P45983 1/20 0.38
MAPK9 P45984 1/20 0.38
MAPK10 P53779 1/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC10 Q969S8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31370047 0.85 KEAP1 (0.49) KEAP1HTR2AHTR2CBACE1PDPK1
SCHEMBL2263387 0.81 HTR2A (0.48) KEAP1HTR2AHTR2CBACE1PDPK1
SCHEMBL2260646 0.78 HTR2A (0.46) KEAP1HTR2AHTR2CBACE1PDPK1
SCHEMBL31370704 0.77 PARP1 (0.49) HTR2APARP1HDAC1HDAC2HDAC6
SCHEMBL29564932 0.77 KEAP1 (0.56) KEAP1BACE1PDPK1BCHEPARP1
SCHEMBL7476355 0.77 KEAP1 (0.56) KEAP1BACE1PDPK1BCHEPARP1
SCHEMBL29860607 0.76 MTNR1A (0.60) MTNR1A
SCHEMBL16034081 0.76 MTNR1A (0.60) MTNR1A
SCHEMBL2262208 0.73 AHR (0.47) KEAP1HTR2AHTR2CBACE1PDPK1
SCHEMBL2261924 0.72 SLC6A4 (0.42) KEAP1HTR2AHTR2CBACE1PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400499-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2024-12-05 US claimed
US-20240400499-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2024-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240400499-A1 NOVEL AMINO ACID DERIVATIVES BCAT1, BCAT2, PELP1 KEAP1 2482/4885HTR2A 2719/4885HTR2C 3757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.